ADC Therapeutics Financial Overview
ADC Therapeutics's market cap is currently $437.29M. The company's EPS TTM is $-0.3; its P/E ratio is ―; ADC Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
